Regis Healthcare Limited (ASX:REG)
Australia · Delayed Price · Currency is AUD 4.710
-0.090 (-1.88%)
Sep 18, 2026, 4:10 PM AEST
Regis Healthcare Revenue
In the fiscal year ending June 30, 2026, Regis Healthcare had annual revenue of 1.35B AUD with 16.30% growth. Regis Healthcare had revenue of 682.85M in the half year ending June 30, 2026, with 27.88% growth.
Revenue
1.35B
Revenue Growth
+16.30%
P/S Ratio
1.05
Revenue / Employee
103.89K
Employees
13,000
Market Cap
1.42B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1.35B | 189.31M | 16.30% |
| Jun 30, 2025 | 1.16B | 147.24M | 14.52% |
| Jun 30, 2024 | 1.01B | 233.44M | 29.91% |
| Jun 30, 2023 | 780.61M | 55.28M | 7.62% |
| Jun 30, 2022 | 725.33M | 23.97M | 3.42% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.83B |
| Ramsay Health Care | 18.58B |
| Sigma Healthcare | 10.83B |
| Integral Diagnostics | 788.62M |
| Pro Medicus | 261.69M |
| Nanosonics | 203.89M |
| Mesoblast | 173.82M |
| Neuren Pharmaceuticals | 69.53M |
Regis Healthcare News
- 16 days ago - Regis Healthcare Shares Sink 29% As Aged Care Sector Faces Fresh Government Funding Uncertainty - International Business Times (Australia)
- 16 days ago - Australia's Regis Healthcare slumps as aged-care funding raise falls short of cost pressures - Reuters
- 26 days ago - Regis Healthcare Earnings Call Transcript: H2 2026 - Transcripts
- 26 days ago - Regis Healthcare Earnings release: H2 2026 - Filings
- 26 days ago - Regis Healthcare Slides: H2 2026 - Filings
- 26 days ago - Regis Healthcare Annual report: H2 2026 - Filings
- 4 months ago - ASX 200 LIVE: Darren Yip named ASX Ltd interim CEO; Woolworths warns Iran war, fuel prices to hit profit; ASX lower for eighth day - The Australian Financial Review
- 4 months ago - ASX 200 Top Gainers Surge as Regis Healthcare Jumps 16% on Budget Optimism and Sector Rotation - International Business Times (Australia)